You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Astrazeneca Pharma India Ltd"

Astrazeneca Pharma India Ltd Termination of distribution arrangements for Meronem in India by AstraZeneca UK Limited - Extension

  • 01/12/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Authorised KMPs to determine materiality of events/information

  • 29/11/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Change in Compliance Officer

  • 15/11/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Resignation of Company Secretary & Compliance Officer

  • 11/11/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Standalone Financial Results Limited Review Report for September 30 2016

  • 11/11/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended S

  • 13/10/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Board Meeting Intimation for Results & Closure of Trading Window

  • 12/10/2016
  • |
  • bse

Astrazeneca Pharma India Ltd AstraZeneca Pharma India Ltd reply to clarification sought by the exchange

  • 04/10/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Clarification sought from AstraZeneca Pharma India Ltd

  • 04/10/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Termination of distribution arrangements for Meronem in India by AstraZeneca UK Limited

  • 24/08/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Updates on Outcome of AGM

  • 12/08/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 12/08/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Standalone Financial Results Limited Review Report for June 30 2016

  • 09/08/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Board Meeting Intimation for Results & Closure of Trading Window

  • 15/07/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended J

  • 13/07/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Declaration regarding Audit Report with unmodified opinion

  • 16/06/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Fixes Book Closure for AGM

  • 10/06/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Standalone Financial Results Auditors Report for March 31 2016

  • 25/05/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Board Intimation for Results & Closure of Trading Window

  • 26/04/2016
  • |
  • bse

Astrazeneca Pharma India Ltd Sun Pharma and AstraZeneca India enter partnership in Type 2 diabetes

  • 23/03/2016
  • |
  • bse

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard